Article · Wikipedia archive · Last revised Jul 26, 2026

VOLT-02

VOLT-02 is a water-soluble conjugate of progesterone and a neurosteroid which is under development by Levolta Pharmaceuticals for the treatment of traumatic brain injury, gynecological disorders, and menstrual disorders. As of March 2017, it is in phase II clinical trials for these indications. The chemical structure of VOLT-02 does not appear to have been released yet.

Last revised
Jul 26, 2026
Read time
≈ 1 min
Length
116 w
Citations
3
Source
Wikipedia ↗
VOLT-02
Clinical data
Other namesProgesterone conjugate
Drug classProgestogen; Neurosteroid
Identifiers
CAS Number

VOLT-02 is a water-soluble conjugate of progesterone and a neurosteroid which is under development by Levolta Pharmaceuticals (formerly Voltarra Pharmaceuticals) for the treatment of traumatic brain injury, gynecological disorders, and menstrual disorders.1 As of March 2017, it is in phase II clinical trials for these indications.1 The chemical structure of VOLT-02 does not appear to have been released yet.1

See also

See also

References

References

External links